Navalign LLC Decreases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Navalign LLC decreased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 7.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,111 shares of the healthcare conglomerate’s stock after selling 88 shares during the period. Navalign LLC’s holdings in UnitedHealth Group were worth $585,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Richelieu Gestion SA bought a new position in UnitedHealth Group in the 4th quarter worth approximately $26,000. Robbins Farley purchased a new position in shares of UnitedHealth Group during the 3rd quarter valued at $25,000. CGC Financial Services LLC boosted its stake in UnitedHealth Group by 1,000.0% during the fourth quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after buying an additional 50 shares during the period. NewSquare Capital LLC boosted its position in shares of UnitedHealth Group by 340.0% during the 3rd quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 51 shares during the last quarter. Finally, Strategic Investment Solutions Inc. IL bought a new position in shares of UnitedHealth Group in the first quarter worth approximately $35,000. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Performance

UNH traded up $1.60 during midday trading on Thursday, hitting $494.70. 3,805,551 shares of the company traded hands, compared to its average volume of 4,097,774. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62. UnitedHealth Group Incorporated has a 52 week low of $445.68 and a 52 week high of $554.70. The firm has a market capitalization of $456.08 billion, a PE ratio of 20.70, a price-to-earnings-growth ratio of 1.34 and a beta of 0.54. The company’s 50-day moving average is $503.10 and its 200 day moving average is $518.61.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Friday, January 12th. The healthcare conglomerate reported $6.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.98 by $0.18. The company had revenue of $94.43 billion during the quarter, compared to the consensus estimate of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The firm’s revenue was up 14.1% on a year-over-year basis. During the same period in the previous year, the company posted $5.34 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 27.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. UnitedHealth Group’s dividend payout ratio (DPR) is 31.54%.

Analyst Ratings Changes

Several brokerages recently issued reports on UNH. Truist Financial reiterated a “buy” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research report on Thursday, November 30th. Piper Sandler reduced their target price on shares of UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating on the stock in a report on Wednesday, January 17th. Bank of America reissued a “buy” rating and issued a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Stephens reissued an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research note on Thursday, February 8th. Finally, Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. One research analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

Insiders Place Their Bets

In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the sale, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Company insiders own 0.35% of the company’s stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.